X
API Suppliers
US DMFs Filed
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
0
Other Suppliers
0
USA (Orange Book)
0
Europe
Canada
0
Australia
0
South Africa
Uploaded Dossiers
U.S. Medicaid
0
Annual Reports
0
0
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-february-22-2023-51785.pdf
https://www.fiercepharma.com/manufacturing/tevas-halt-production-troubled-plant-seen-create-shortages-range-injectables
https://www.prnewswire.com/news-releases/insmed-initiates-frontline-clinical-trial-program-for-arikayce-amikacin-liposome-inhalation-suspension-in-patients-with-mac-lung-disease-301198251.html
https://www.prnewswire.com/news-releases/valeo-pharma-announces-amikacin-approval-in-canada-and-us-launch-of-ethacrynate-sodium-301171555.html
https://www.raps.org/news-and-articles/news-articles/2020/7/ema-thumbs-up-for-11-down-for-2-new-medicines
https://www.prnewswire.com/news-releases/new-ntm-treatment-guidelines-recommend-insmeds-arikayce-amikacin-liposome-inhalation-suspension-for-treatment-of-patients-with-refractory-mac-lung-disease-301088735.html
https://www.raps.org/news-and-articles/news-articles/2019/1/fdas-record-year-a-look-at-2018-new-drug-approva?utm_source=MagnetMail&utm_medium=Email%20&utm_campaign=RF%20Today%20%7C%207%20January
https://www.prnewswire.com/news-releases/pantherx-specialty-pharmacy-selected-by-insmed-to-distribute-arikayce-amikacin-liposome-inhalation-suspension-300768182.html
https://www.reuters.com/article/us-insmed-fda/insmeds-treatment-resistant-lung-disease-drug-gets-fda-approval-idUSKCN1M82TC
http://www.accessdata.fda.gov/scripts/enforcement/enforce_rpt-Product-Tabs.cfm?action=select&recall_number=D-0341-2015&w=01282015&lang=eng
Market Place
Share 
